T. Rowe Price Associates’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $821M | Sell |
|
|||||
2025
Q1 | $963M | Buy |
|
|||||
2024
Q4 | $1.03B | Buy |
|
|||||
2024
Q3 | $951M | Buy |
|
|||||
2024
Q2 | $581M | Buy |
|
|||||
2024
Q1 | $656M | Sell |
|
|||||
2023
Q4 | $721M | Buy |
|
|||||
2023
Q3 | $605M | Buy |
|
|||||
2023
Q2 | $526M | Sell |
|
|||||
2023
Q1 | $633M | Sell |
|
|||||
2022
Q4 | $859M | Buy |
|
|||||
2022
Q3 | $685M | Sell |
|
|||||
2022
Q2 | $898M | Buy |
|
|||||
2022
Q1 | $710M | Buy |
|
|||||
2021
Q4 | $806M | Buy |
|
|||||
2021
Q3 | $666M | Buy |
|
|||||
2021
Q2 | $350M | Buy |
|
|||||
2021
Q1 | $256M | Buy |
|
|||||
2020
Q4 | $228M | Buy |
|
|||||
2020
Q3 | $144M | Sell |
|
|||||
2020
Q2 | $220M | Sell |
|
|||||
2020
Q1 | $198M | Buy |
|
|||||
2019
Q4 | $59.9M | Buy |
|
|||||
2019
Q3 | $49.3M | Buy |
|
|||||
2019
Q2 | $52.6M | Buy |
|
|||||
2019
Q1 | $34.8M | Buy |
|
|||||
2018
Q4 | $30.7M | Buy |
|
|||||
2018
Q3 | $30.1M | Buy |
|
|||||
2018
Q2 | $21.8M | Buy |
|
|||||
2018
Q1 | $16.3M | Buy |
|
|||||
2017
Q4 | $15.9M | Buy |
|
|||||
2017
Q3 | $16.7M | Buy |
|
|||||
2017
Q2 | $16.2M | Buy |
|
|||||
2017
Q1 | $11.5M | Buy |
|
|||||
2016
Q4 | $7.73M | Buy |
|
|||||
2016
Q3 | $7.52M | Buy |
|
|||||
2016
Q2 | $5.59M | Buy |
|
|||||
2016
Q1 | $5.15M | Buy |
|
|||||
2015
Q4 | $5.38M | Buy |
|
|||||
2015
Q3 | $4.37M | Buy |
|
|||||
2015
Q2 | $4.75M | Buy |
|